Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives

Discuss the definition of NAFLD and the various phenotypes
Identify how to risk stratify those with NAFLD
Discuss the basic management of patients with NASH and fibrosis

Target Audience

Family Medicine department providers, nurses, medical assistants, case managers, WIC staff as well as Adult, WH and Pediatrics providers.

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement:

Michelle Long, Speaker, has nothing to disclose with regard to commercial interests.

Judith Loh, CME Course Director, has nothing to disclose with regard to commercial interests.

Sakina Flint, RSS Coordinator, has nothing to disclose with regard to commercial interests.

Faculty disclosure of off-label use:

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.